Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yangzheng Compound Mixture for Sleep Disorder in Cancer Patients
NCT04641819Phase 4Active, not recruiting
- Sponsor
- Shuguang Hospital
- Start
- Apr 2021
- Primary completion
- Sep 2023
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 4 trial of Yangzheng Compound Mixture in sleep disorder, sponsored by Shuguang Hospital. Started Apr 2021; status: active, not recruiting.
02
Drugs
Yangzheng Compound Mixture
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT04641819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04641819.